查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1485862

奈米技術藥物傳輸市場，依技術類型、管理模式、應用、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Nanotechnology Drug Delivery Market, By Technology Type, By Mode of Administration, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 284 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2023年奈米技術藥物輸送市場規模為891.9843億美元，2024年至2032年複合年成長率為9.81%。

奈米技術藥物傳輸市場-市場動態

慢性病發病率上升推動對先進奈米技術藥物傳輸解決方案的需求

全球慢性病發病率不斷上升，推動了對先進奈米技術藥物傳輸解決方案的需求。例如，根據世界衛生組織 (WHO) 的數據，非傳染性疾病 (NCD) 約佔全球死亡人數的 71%，其中心血管疾病、癌症、呼吸系統疾病和糖尿病是主要原因。為了應對這項健康課題，美國國立衛生研究院 (NIH) 等組織擴大投資於奈米醫學研究，以開發能夠有效治療慢性病同時最大限度減少副作用的標靶藥物輸送系統。此外，輝瑞和諾華等製藥公司正在積極探索基於奈米技術的藥物傳輸平台，以提高慢性病治療的效果和患者的依從性。對創新藥物輸送解決方案的日益重視凸顯了透過奈米技術進步解決慢性疾病負擔的迫切需求。

奈米技術藥物傳輸市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 9.81% 左右的複合年成長率成長

根據技術類型區隔，預計奈米粒子將在 2023 年顯示最大的市場佔有率

依給藥方式區隔，2023年靜脈給藥為主導類型

依地區分類，北美是 2023 年的主要收入來源

奈米技術藥物傳輸市場-區隔分析：

全球奈米技術藥物傳輸市場根據技術類型、管理模式、應用和區域進行區隔。

根據技術類型，市場分為五類：奈米晶體、奈米粒子、脂質體、膠束和樹枝狀聚合物。由於奈米顆粒在靶向藥物傳輸方面的多功能性和有效性，已成為奈米技術藥物傳輸市場的主導技術類型。透過精確控制尺寸和表面特性，奈米顆粒可提供增強的穩定性、生物相容性和治療有效負載能力，從而推動其更高的市場採用率。

根據給藥方式，市場分為四類：口服、靜脈注射、經皮和吸入。靜脈給藥因其直接進入全身循環且起效快而成為奈米技術給藥市場的主要模式。這種模式可以精確控制藥物輸送，使其適合需要立即治療介入的危急醫療狀況。

奈米技術藥物傳輸市場 - 地理洞察

北美由於強大的研究基礎設施以及對醫療保健和奈米技術的高投資而引領市場，安進公司和強生等公司開創了創新的藥物輸送系統。在歐洲，瑞士和英國等國家正在見證重大進步，羅氏控股公司和阿斯特捷利康公司等公司投資於基於奈米技術的解決方案。與此同時，以印度和日本為首的亞太地區在醫療保健支出增加和慢性病患病率上升的推動下正在經歷快速成長。 Sun Pharmaceutical Industries Ltd 和 Takeda Pharmaceutical Company Limited 等地區企業正在利用奈米技術開發客製化的藥物輸送系統。

奈米技術藥物輸送市場-競爭格局：

安進公司、強生公司等領先公司約翰遜、羅氏控股公司和阿斯特捷利康公司處於領先地位，在研發方面進行了大量投資，以創新基於奈米技術的新型藥物輸送系統。這些公司專注於開發有針對性的高效藥物傳輸平台，以改善治療效果和患者依從性。此外，策略合作、夥伴關係和收購是市場參與者為加強產品組合和擴大地理影響力而採用的常見策略。例如，2022年，全球製藥公司輝瑞宣布與專門從事奈米醫學的生物技術公司BIND Therapeutics合作。此次合作旨在利用 BIND 的 Accurin 技術（一種利用奈米顆粒的靶向藥物傳輸平台）來增強輝瑞腫瘤治療藥物的傳輸。這種夥伴關係促進了新型癌症治療方法的開發，提高了療效並減少了副作用。新創企業和新創公司也透過引入顛覆性技術和利基藥物輸送解決方案來提高市場競爭力。

最近的發展：

2021年9月，Nanovis宣布推出首款也是唯一一款生物陶瓷奈米管增強椎弓根螺釘系統nano fortifix(R)，展示了一款開創性的奈米技術增強椎弓根螺釘系統，標籤聲稱可增強骨骼生長

2020 年 7 月，Curadigm 宣布從 BPI France 的 Deep Tech Program 獲得 100 萬歐元資金，以支持 Nanoprimer 平台的開發，強調對其 Nanoprimer 技術進行大量投資，以提高各種藥物類別的治療生物利用度和功效

目錄

第1章：奈米技術藥物傳輸市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 依技術類型分類的奈米技術藥物傳輸市場片段
    • 依管理模式分類的奈米技術藥物傳輸市場片段
    • 奈米技術藥物傳輸市場片段（依應用）
    • 依國家/地區分類的奈米技術藥物傳輸市場片段
    • 依地區分類的奈米技術藥物傳輸市場片段
  • 競爭洞察

第 3 章：奈米技術藥物傳輸主要市場趨勢

  • 奈米技術藥物傳輸市場促進因素
    • 市場促進因素的影響分析
  • 奈米技術藥物傳輸市場的限制
    • 市場限制影響分析
  • 奈米技術藥物輸送市場機會
  • 奈米技術藥物傳輸市場未來趨勢

第 4 章：奈米技術藥物傳輸產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：奈米技術藥物輸送市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：奈米技術藥物傳輸市場格局

  • 2023 年奈米技術藥物傳輸市場佔有率分析
  • 依主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：奈米技術藥物傳輸市場 - 依技術類型

  • 概述
    • 依技術類型分類的區隔市場佔有率分析
    • 奈米晶體
    • 奈米粒子
    • 脂質體
    • 膠束
    • 樹枝狀聚合物
    • 其他

第 8 章：奈米技術藥物傳輸市場 - 依給藥模式

  • 概述
    • 依管理模式分類的區隔市場佔有率分析
    • 口服
    • 靜脈
    • 經皮
    • 吸入
    • 其他

第 9 章：奈米技術藥物傳輸市場 - 依應用

  • 概述
    • 依應用分類的區隔市場佔有率分析
    • 腫瘤學
    • 心血管疾病
    • 神經病學
    • 抗發炎/免疫學
    • 抗感染
    • 其他

第 10 章：奈米技術藥物傳輸市場 - 依地理位置

  • 介紹
    • 依地理位置分類的區隔市場佔有率分析
  • 北美洲
    • 概述
    • 北美奈米技術藥物傳輸主要製造商
    • 北美市場規模和預測（依國家）
    • 北美市場規模和預測（依技術類型）
    • 北美市場規模與預測（依管理模式）
    • 北美市場規模和預測（依應用）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲奈米技術藥物傳輸主要製造商
    • 歐洲市場規模和預測（依國家）
    • 歐洲市場規模和預測（依技術類型）
    • 歐洲市場規模與預測（依管理模式）
    • 歐洲市場規模和預測（依應用）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區奈米技術藥物傳輸主要製造商
    • 亞太地區市場規模與預測（依國家）
    • 亞太地區市場規模與預測（依技術類型）
    • 亞太地區市場規模與預測（依管理模式）
    • 亞太地區市場規模與預測（依應用）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲奈米技術藥物傳輸主要製造商
    • 拉丁美洲市場規模與預測（依國家）
    • 拉丁美洲市場規模與預測（依技術類型）
    • 拉丁美洲市場規模與預測（依管理模式）
    • 拉丁美洲市場規模與預測（依應用）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲奈米技術藥物傳輸主要製造商
    • 中東和非洲市場規模及預測（依國家）
    • 中東和非洲市場規模及預測（依技術類型）
    • 中東和非洲市場規模及預測（依管理模式）
    • 中東和非洲市場規模及預測（依應用）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章：主要供應商分析 - 奈米技術藥物輸送產業

  • 競爭儀表板
  • 公司簡介
    • AbbVie Inc.
    • Amgen Inc.
    • AstraZeneca plc
    • Bristol-Myers Squibb Company
    • Celator Pharmaceuticals Inc
    • Celgene Corporation
    • Celsion Corporation
    • GlaxoSmithKline plc
    • Johnson & Johnson
    • Merck & Co., Inc.
    • Nanobiotix SA
    • Novartis International AG
    • Pfizer Inc.
    • Roche Holding AG
    • Sanofi SA
    • Teva Pharmaceutical Industries Ltd.
    • Others

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV2766

REPORT HIGHLIGHT

Nanotechnology Drug Delivery Market size was valued at USD 89,198.43 Million in 2023, expanding at a CAGR of 9.81% from 2024 to 2032.

The Nanotechnology Drug Delivery Market, leveraging nanoscale materials for targeted and efficient drug delivery, is poised for significant growth. The potential for enhanced drug efficacy and reduced side effects, increasing investments in nanomedicine research, and the rising prevalence of chronic diseases demanding novel therapeutic solutions drive market growth. However, market growth is restrained by challenges such as regulatory complexities, concerns regarding toxicity and biocompatibility, and high research and development costs. Opportunities lie in the development of novel nanocarriers for gene therapy, personalized medicine, and the utilization of nanotechnology for overcoming biological barriers, thereby expanding the scope of drug delivery applications.

Nanotechnology Drug Delivery Market- Market Dynamics

Rising Chronic Disease Rates Propel Demand for Advanced Nanotechnology Drug Delivery Solutions

The escalating rates of chronic diseases worldwide are driving the demand for advanced nanotechnology drug delivery solutions. For instance, according to the World Health Organization (WHO), non-communicable diseases (NCDs) account for approximately 71% of all deaths globally, with cardiovascular diseases, cancer, respiratory diseases, and diabetes being the leading causes. In response to this health challenge, organizations like the National Institutes of Health (NIH) in the United States are increasingly investing in nanomedicine research to develop targeted drug delivery systems that can effectively treat chronic conditions while minimizing side effects. Additionally, pharmaceutical companies such as Pfizer and Novartis are actively exploring nanotechnology-based drug delivery platforms to enhance therapeutic outcomes and patient compliance in the treatment of chronic diseases. This growing emphasis on innovative drug delivery solutions underscores the urgent need to address the burden of chronic illnesses through nanotechnology advancements.

Nanotechnology Drug Delivery Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 9.81% over the forecast period (2024-2032)

Based on Technology Type segmentation, Nanoparticles were predicted to show maximum market share in the year 2023

Based on Mode of Administration segmentation, Intravenous was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Nanotechnology Drug Delivery Market- Segmentation Analysis:

The Global Nanotechnology Drug Delivery Market is segmented on the basis of Technology Type, Mode of Administration, Application, and Region.

The market is divided into five categories based on Technology Type: Nanocrystals, Nanoparticles, Liposomes, Micelles, and Dendrimers. Nanoparticles have emerged as the dominant technology type in the Nanotechnology Drug Delivery Market due to their versatility and effectiveness in targeted drug delivery. With precise control over size and surface properties, nanoparticles offer enhanced stability, biocompatibility, and therapeutic payload capacity, driving their higher market adoption.

The market is divided into four categories based on the Mode of Administration: Oral, Intravenous, Transdermal, and Inhalation. Intravenous administration stands out as the primary mode in the Nanotechnology Drug Delivery Market, owing to its direct access to systemic circulation and rapid onset of action. This mode offers precise control over drug delivery, making it suitable for critical medical conditions requiring immediate therapeutic intervention.

Nanotechnology Drug Delivery Market- Geographical Insights

North America leads the market due to robust research infrastructure and high investments in healthcare and nanotechnology, with players like Amgen Inc. and Johnson & Johnson pioneering innovative drug delivery systems. In Europe, countries like Switzerland and the United Kingdom are witnessing significant advancements, with companies such as Roche Holding AG and AstraZeneca PLC investing in nanotechnology-based solutions. Meanwhile, the Asia Pacific region, led by India and Japan, is experiencing rapid growth fueled by increasing healthcare expenditure and rising chronic disease prevalence. Regional players like Sun Pharmaceutical Industries Ltd. and Takeda Pharmaceutical Company Limited are leveraging nanotechnology to develop tailored drug delivery systems.

Nanotechnology Drug Delivery Market- Competitive Landscape:

Leading companies such as Amgen Inc., Johnson & amp; Johnson, Roche Holding AG, and AstraZeneca PLC are at the forefront, investing significantly in research and development to innovate novel nanotechnology-based drug delivery systems. These companies focus on developing targeted and efficient drug delivery platforms to improve therapeutic outcomes and patient compliance. Additionally, strategic collaborations, partnerships, and acquisitions are common strategies employed by market players to strengthen their product portfolios and expand their geographic presence. For instance, in 2022, Pfizer, a global pharmaceutical company, announced a collaboration with BIND Therapeutics, a biotechnology company specializing in nanomedicine. The collaboration aimed to utilize BIND's Accurin technology, a targeted drug delivery platform utilizing nanoparticles, to enhance the delivery of Pfizer's oncology therapeutics. This partnership facilitated the development of novel cancer treatments with improved efficacy and reduced side effects. Emerging players and startups are also contributing to market competitiveness by introducing disruptive technologies and niche drug delivery solutions.

Recent Developments:

In September 2021, Nanovis announced the launch of the first and only bioceramic nanotube-enhanced pedicle screw system, nano fortifix(R), showcasing a pioneering nanotechnology-enhanced pedicle screw system with label claims to enhance bone growth

In July 2020, Curadigm Announces EUR 1 million in funding from BPI France's Deep Tech Program to Support the Development of the Nanoprimer Platform, highlighting a substantial investment in their Nanoprimer technology to enhance therapeutic bioavailability and efficacy across various drug classes

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NANOTECHNOLOGY DRUG DELIVERY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

AbbVie Inc.

Amgen Inc.

AstraZeneca plc

Bristol-Myers Squibb Company

Celator Pharmaceuticals Inc

Celgene Corporation

Celsion Corporation

GlaxoSmithKline plc

Johnson & Johnson

Merck & Co., Inc.

Nanobiotix S.A.

Novartis International AG

Pfizer Inc.

Roche Holding AG

Sanofi S.A.

Teva Pharmaceutical Industries Ltd.

Others

GLOBAL NANOTECHNOLOGY DRUG DELIVERY MARKET, BY TECHNOLOGY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Nanocrystals
  • Nanoparticles
  • Liposomes
  • Micelles
  • Dendrimers
  • Others

GLOBAL NANOTECHNOLOGY DRUG DELIVERY MARKET, BY MODE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032

  • Oral
  • Intravenous
  • Transdermal
  • Inhalation
  • Others

GLOBAL NANOTECHNOLOGY DRUG DELIVERY MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Oncology
  • Cardiovascular Diseases
  • Neurology
  • Anti-inflammatory/Immunology
  • Anti-infective
  • Others

GLOBAL NANOTECHNOLOGY DRUG DELIVERY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Nanotechnology Drug Delivery Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Nanotechnology Drug Delivery Market Snippet by Technology Type
    • 2.1.2.Nanotechnology Drug Delivery Market Snippet by Mode of Administration
    • 2.1.3.Nanotechnology Drug Delivery Market Snippet by Application
    • 2.1.4.Nanotechnology Drug Delivery Market Snippet by Country
    • 2.1.5.Nanotechnology Drug Delivery Market Snippet by Region
  • 2.2.Competitive Insights

3.Nanotechnology Drug Delivery Key Market Trends

  • 3.1.Nanotechnology Drug Delivery Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Nanotechnology Drug Delivery Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Nanotechnology Drug Delivery Market Opportunities
  • 3.4.Nanotechnology Drug Delivery Market Future Trends

4.Nanotechnology Drug Delivery Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Nanotechnology Drug Delivery Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Nanotechnology Drug Delivery Market Landscape

  • 6.1.Nanotechnology Drug Delivery Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Nanotechnology Drug Delivery Market - By Technology Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Technology Type, 2023 & 2032 (%)
    • 7.1.2.Nanocrystals
    • 7.1.3.Nanoparticles
    • 7.1.4.Liposomes
    • 7.1.5.Micelles
    • 7.1.6.Dendrimers
    • 7.1.7.Others

8.Nanotechnology Drug Delivery Market - By Mode of Administration

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Mode of Administration, 2023 & 2032 (%)
    • 8.1.2.Oral
    • 8.1.3.Intravenous
    • 8.1.4.Transdermal
    • 8.1.5.Inhalation
    • 8.1.6.Others

9.Nanotechnology Drug Delivery Market - By Application

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 9.1.2.Oncology
    • 9.1.3.Cardiovascular Diseases
    • 9.1.4.Neurology
    • 9.1.5.Anti-inflammatory/Immunology
    • 9.1.6.Anti-infective
    • 9.1.7.Others

10.Nanotechnology Drug Delivery Market- By Geography

  • 10.1.Introduction
    • 10.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2.North America
    • 10.2.1.Overview
    • 10.2.2.Nanotechnology Drug Delivery Key Manufacturers in North America
    • 10.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4.North America Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
    • 10.2.5.North America Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
    • 10.2.6.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.7.U.S.
      • 10.2.7.1.Overview
      • 10.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3.U.S. Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4.U.S. Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.2.7.5.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.8.Canada
      • 10.2.8.1.Overview
      • 10.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3.Canada Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4.Canada Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.2.8.5.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3.Europe
    • 10.3.1.Overview
    • 10.3.2.Nanotechnology Drug Delivery Key Manufacturers in Europe
    • 10.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4.Europe Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
    • 10.3.5.Europe Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
    • 10.3.6.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.7.Germany
      • 10.3.7.1.Overview
      • 10.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3.Germany Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4.Germany Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.3.7.5.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.8.Italy
      • 10.3.8.1.Overview
      • 10.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3.Italy Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4.Italy Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.3.8.5.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.9.United Kingdom
      • 10.3.9.1.Overview
      • 10.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3.United Kingdom Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4.United Kingdom Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.3.9.5.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.10.France
      • 10.3.10.1.Overview
      • 10.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3.France Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4.France Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.3.10.5.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.11.Russia
      • 10.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2.Russia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3.Russia Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.3.11.4.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.12.Netherlands
      • 10.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2.Netherlands Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3.Netherlands Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.3.12.4.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.13.Sweden
      • 10.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2.Sweden Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3.Sweden Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.3.13.4.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.14.Poland
      • 10.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2.Poland Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3.Poland Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.3.14.4.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.15.Rest of Europe
      • 10.3.15.1.Overview
      • 10.3.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3.Rest of the Europe Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4.Rest of the Europe Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.3.15.5.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4.Asia Pacific (APAC)
    • 10.4.1.Overview
    • 10.4.2.Nanotechnology Drug Delivery Key Manufacturers in Asia Pacific
    • 10.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4.Asia Pacific Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
    • 10.4.5.Asia Pacific Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
    • 10.4.6.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.7.India
      • 10.4.7.1.Overview
      • 10.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3.India Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4.India Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.4.7.5.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.8.China
      • 10.4.8.1.Overview
      • 10.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3.China Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4.China Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.4.8.5.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.9.Japan
      • 10.4.9.1.Overview
      • 10.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3.Japan Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4.Japan Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.4.9.5.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.10.South Korea
      • 10.4.10.1.Overview
      • 10.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3.South Korea Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4.South Korea Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.4.10.5.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.11.Australia
      • 10.4.11.1.Overview
      • 10.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3.Australia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4.Australia Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.4.11.5.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.12.Thailand
      • 10.4.12.1.Overview
      • 10.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3.Thailand Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4.Thailand Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.4.12.5.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.13.Indonesia
      • 10.4.13.1.Overview
      • 10.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3.Indonesia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4.Indonesia Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.4.13.5.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.14.Philippines
      • 10.4.14.1.Overview
      • 10.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3.Philippines Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4.Philippines Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.4.14.5.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.15.Rest of APAC
      • 10.4.15.1.Overview
      • 10.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3.Rest of APAC Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4.Rest of APAC Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.4.15.5.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.5.Latin America
    • 10.5.1.Overview
    • 10.5.2.Nanotechnology Drug Delivery Key Manufacturers in Latin America
    • 10.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4.Latin America Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
    • 10.5.5.Latin America Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
    • 10.5.6.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.7.Brazil
      • 10.5.7.1.Overview
      • 10.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3.Brazil Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4.Brazil Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.5.7.5.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.8.Mexico
      • 10.5.8.1.Overview
      • 10.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3.Mexico Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4.Mexico Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.5.8.5.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.9.Argentina
      • 10.5.9.1.Overview
      • 10.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3.Argentina Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4.Argentina Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.5.9.5.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.10.Colombia
      • 10.5.10.1.Overview
      • 10.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3.Colombia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4.Colombia Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.5.10.5.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.11.Rest of LATAM
      • 10.5.11.1.Overview
      • 10.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3.Rest of LATAM Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4.Rest of LATAM Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.5.11.5.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.6.Middle East and Africa
    • 10.6.1.Overview
    • 10.6.2.Nanotechnology Drug Delivery Key Manufacturers in Middle East and Africa
    • 10.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4.Middle East and Africa Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
    • 10.6.5.Middle East and Africa Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
    • 10.6.6.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.7.Saudi Arabia
      • 10.6.7.1.Overview
      • 10.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3.Saudi Arabia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4.Saudi Arabia Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.6.7.5.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.8.United Arab Emirates
      • 10.6.8.1.Overview
      • 10.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3.United Arab Emirates Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4.United Arab Emirates Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.6.8.5.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.9.Israel
      • 10.6.9.1.Overview
      • 10.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3.Israel Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4.Israel Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.6.9.5.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.10.Turkey
      • 10.6.10.1.Overview
      • 10.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3.Turkey Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4.Turkey Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.6.10.5.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.11.Algeria
      • 10.6.11.1.Overview
      • 10.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3.Algeria Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4.Algeria Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.6.11.5.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.12.Egypt
      • 10.6.12.1.Overview
      • 10.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3.Egypt Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4.Egypt Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.6.12.5.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.13.Rest of MEA
      • 10.6.13.1.Overview
      • 10.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3.Rest of MEA Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4.Rest of MEA Market Size and Forecast, By Mode of Administration, 2019 - 2032 (US$ Million)
      • 10.6.13.5.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

11.Key Vendor Analysis- Nanotechnology Drug Delivery Industry

  • 11.1.Competitive Dashboard
  • 11.2.Company Profiles
    • 11.2.1.AbbVie Inc.
    • 11.2.2.Amgen Inc.
    • 11.2.3.AstraZeneca plc
    • 11.2.4.Bristol-Myers Squibb Company
    • 11.2.5.Celator Pharmaceuticals Inc
    • 11.2.6.Celgene Corporation
    • 11.2.7.Celsion Corporation
    • 11.2.8.GlaxoSmithKline plc
    • 11.2.9.Johnson & Johnson
    • 11.2.10.Merck & Co., Inc.
    • 11.2.11.Nanobiotix S.A.
    • 11.2.12.Novartis International AG
    • 11.2.13.Pfizer Inc.
    • 11.2.14.Roche Holding AG
    • 11.2.15.Sanofi S.A.
    • 11.2.16.Teva Pharmaceutical Industries Ltd.
    • 11.2.17.Others

12.360 Degree Analyst View

13.Appendix

  • 13.1.Research Methodology
  • 13.2.References
  • 13.3.Abbreviations
  • 13.4.Disclaimer
  • 13.5.Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Nanotechnology Drug Delivery Market: Technology Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Technology Type
  • TABLE Global Nanotechnology Drug Delivery Market, by Technology Type 2019-2032 (USD Million)
  • TABLE Nanotechnology Drug Delivery Market: Mode of Administration Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Mode of Administration
  • TABLE Global Nanotechnology Drug Delivery Market, by Mode of Administration 2019-2032 (USD Million)
  • TABLE Nanotechnology Drug Delivery Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Nanotechnology Drug Delivery Market, by Application 2019-2032 (USD Million)
  • TABLE Nanotechnology Drug Delivery Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Nanotechnology Drug Delivery Market, by Region 2019-2032 (USD Million)
  • TABLE North America Nanotechnology Drug Delivery Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Nanotechnology Drug Delivery Market, by Technology Type, 2019-2032 (USD Million)
  • TABLE North America Nanotechnology Drug Delivery Market, by Mode of Administration, 2019-2032 (USD Million)
  • TABLE North America Nanotechnology Drug Delivery Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Nanotechnology Drug Delivery Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Nanotechnology Drug Delivery Market, by Technology Type, 2019-2032 (USD Million)
  • TABLE Europe Nanotechnology Drug Delivery Market, by Mode of Administration, 2019-2032 (USD Million)
  • TABLE Europe Nanotechnology Drug Delivery Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Nanotechnology Drug Delivery Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Nanotechnology Drug Delivery Market, by Technology Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Nanotechnology Drug Delivery Market, by Mode of Administration, 2019-2032 (USD Million)
  • TABLE Asia Pacific Nanotechnology Drug Delivery Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Nanotechnology Drug Delivery Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Nanotechnology Drug Delivery Market, by Technology Type, 2019-2032 (USD Million)
  • TABLE Latin America Nanotechnology Drug Delivery Market, by Mode of Administration, 2019-2032 (USD Million)
  • TABLE Latin America Nanotechnology Drug Delivery Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Nanotechnology Drug Delivery Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Nanotechnology Drug Delivery Market, by Technology Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Nanotechnology Drug Delivery Market, by Mode of Administration, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Nanotechnology Drug Delivery Market, by Application, 2019-2032 (USD Million)